Transition Therapeutics Inc (TTH.TO)

A speculative pick. They are going after diabetes, one of the biggest health problems in the world. So far, test have only been done with mice but success has been good. Risky, so don't invest too much. High risk/high reward.

Have some early-stage products which makes it a cheap company. A higher risk name. Good management.